The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Dapagliflozin to Improve Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure
Not Applicable
- Conditions
- Atrial Fibrillation in Patients with Heart Failure
- Registration Number
- JPRN-UMIN000042603
- Lead Sponsor
- Showa University Northern Yokohama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are intolerant for SGLT-2 inhibitor Patients with renal insufficiency (estimated GFR < 30) When the attending physician consider inappropriate to enroll the patient in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method